Literature DB >> 29710431

Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.

A-S Darrigade1,2, A Legrand1, N Andreu1, C Jacquemin2, K Boniface2, A Taïeb1, J Seneschal1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29710431     DOI: 10.1111/bjd.16711

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

Review 1.  Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.

Authors:  Cheng Zhou; Xiangqian Li; Chen Wang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-17       Impact factor: 8.667

Review 2.  [Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Authors:  Stephan Traidl; Annice Heratizadeh
Journal:  Dermatologie (Heidelb)       Date:  2022-06-01

Review 3.  Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Authors:  Reinhart Speeckaert; Jo Lambert; Nanja van Geel
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

4.  Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.

Authors:  Sunny Park; So Hyang Park; Young Joo Byun; Soo An Choi
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

5.  Alopecia areata in 2 patients treated with dupilumab: New onset and worsening.

Authors:  Janice Chung; Christa L Slaught; Eric L Simpson
Journal:  JAAD Case Rep       Date:  2019-07-30

6.  Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.

Authors:  Reiko Kageyama; Taisuke Ito; Shiho Hanai; Naomi Morishita; Shinsuke Nakazawa; Toshiharu Fujiyama; Tetsuya Honda; Yoshiki Tokura
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

7.  Can't handle the itch? Refractory immunotherapy-related transient acantholytic dermatosis: prompt resolution with dupilumab.

Authors:  Eva Shelton; Coley Doolittle; Michi M Shinohara; John A Thompson; Ata S Moshiri
Journal:  JAAD Case Rep       Date:  2022-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.